Quest Laboratories Share Price Target Tomorrow 2025 To 2030
Quest Laboratories is a healthcare company that provides medical testing and diagnostic services. It plays an important role in helping doctors and patients understand health conditions through accurate lab results. The company is known for using modern technology to offer reliable and fast testing services. Quest Laboratories focuses on quality, safety, and customer care, which has helped it build trust in the healthcare community. Quest Laboratories Share Price on BOM as of 7 May 2025 is 21.31 INR.
Quest Laboratories Share Market Overview
- Open: 111.50
- High: 114.40
- Low: 111.00
- Previous Close: 109.70
- 52 Week High: 196.80
- 52 Week Low: 85.10
- Mkt Cap (Rs. Cr.): 180
- Face Value: 10.00
Quest Laboratories Share Price Chart
Quest Laboratories Shareholding Pattern
- Promoters: 66.2%
- FII: 1%
- DII: 2.1%
- Public: 30.8%
Quest Laboratories Share Price Target Tomorrow 2025 To 2030
| Quest Laboratories Share Price Target Years | Quest Laboratories Share Price |
| 2025 | ₹200 |
| 2026 | ₹260 |
| 2027 | ₹320 |
| 2028 | ₹380 |
| 2029 | ₹440 |
| 2030 | ₹500 |
Quest Laboratories Share Price Target 2025
Quest Laboratories share price target 2025 Expected target could ₹200. Here are four key factors that could influence the growth of Quest Laboratories Ltd. and its share price target for 2025:
1. Strong Financial Performance and Profitability
Quest Laboratories has demonstrated consistent financial growth. For the fiscal year ending March 2024, the company reported a total revenue of ₹82.79 crore, up from ₹61.87 crore in FY 2023, marking a 33.82% year-over-year increase. The profit after tax for FY 2024 stood at ₹11.8 crore, reflecting a net profit margin of 12.19% . Such robust financial performance indicates operational efficiency and a strong market position, which are positive indicators for potential investors.
2. Expansion of Product Portfolio and R&D Investments
The company is actively expanding its product portfolio through dedicated research and development efforts. An in-house R&D department focuses on formulation development, quality control, and product stability studies . This commitment to innovation enables Quest Laboratories to introduce new products, meet diverse customer needs, and stay competitive in the pharmaceutical industry.
3. Healthy Return Ratios and Low Debt Levels
Quest Laboratories boasts impressive financial ratios, with a Return on Equity (ROE) of 46.15% and an operating margin of 18.14% . Additionally, the company maintains a low debt-to-equity ratio of 0.12 , indicating prudent financial management. These metrics suggest that the company is effectively utilizing its capital to generate profits while maintaining financial stability.
4. Strategic Initiatives for Market Expansion
Quest Laboratories is implementing strategic initiatives to expand its market presence. Plans include diversifying the product base, introducing new product lines, and exploring opportunities in international markets . Such initiatives aim to enhance the company’s competitiveness and drive long-term growth.
Quest Laboratories Share Price Target 2030
Quest Laboratories share price target 2030 Expected target could ₹500. Here are 4 potential Risks and Challenges that could impact Quest Laboratories’ share price target by 2030:
-
Regulatory Hurdles and Compliance Risks
Stricter regulations in the pharmaceutical and diagnostics sectors, both locally and globally, could increase operational costs or limit product approvals, directly affecting growth and profitability. -
Technological Disruption and Competition
Rapid advancements in medical testing technologies and increased competition from global and domestic players could erode Quest Laboratories’ market share and pressure margins. -
Dependence on Government Contracts and Healthcare Policies
If the company relies heavily on government contracts or reimbursement policies, changes in healthcare spending or public health priorities may adversely affect revenue streams. -
Operational and Supply Chain Risks
Challenges in sourcing critical raw materials, disruptions in global supply chains, or failures in maintaining quality control standards could damage reputation and financial performance.
Read Also:- Mercury Trade Share Price Target Tomorrow 2025 To 2030
